Phase 2 Clinical Data -- Published results include a complete clinical response in a 49-year-old man with metastatic ...

Total Revenue-- $104,000,000 in total revenue (GAAP) for Q2 2025, reflecting 30.6% year-over-year growth mainly driven by increased revenue from major business operations. Subscription Revenue-- ...

Ronald W. McClurg, CFO, said, "product revenue increased 105% to $1.7 million" and cited "sizable improvements year-over-year ...